These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 24851620)

  • 1. Diagnostic value of MPO in patients admitted for suspected acute coronary syndrome--a study of adult in Mostar, Bosnia and Herzegovina.
    Vasilj M; Starcević B; Volarić M; Jelavić B; Leventić M; Cuk D; Corić S
    Coll Antropol; 2014 Mar; 38(1):213-7. PubMed ID: 24851620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic efficacy of myeloperoxidase for the detection of acute coronary syndromes.
    Sawicki M; Sypniewska G; Kozinski M; Gruszka M; Krintus M; Obonska K; Pilaczynska-Cemel M; Kubica J
    Eur J Clin Invest; 2011 Jun; 41(6):667-71. PubMed ID: 21226709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic and prognostic performance of myeloperoxidase plasma levels compared with sensitive troponins in patients admitted with acute onset chest pain.
    Rudolph V; Keller T; Schulz A; Ojeda F; Rudolph TK; Tzikas S; Bickel C; Meinertz T; Münzel T; Blankenberg S; Baldus S
    Circ Cardiovasc Genet; 2012 Oct; 5(5):561-8. PubMed ID: 22923422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is it safe to discharge patients from accident and emergency using a rapid point of care Triple Cardiac Marker test to rule out acute coronary syndrome in low to intermediate risk patients presenting with chest pain?
    Rathore S; Knowles P; Mann AP; Dodds PA
    Eur J Intern Med; 2008 Nov; 19(7):537-40. PubMed ID: 19013384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myeloperoxidase is not useful for the early assessment of patients with chest pain.
    Eggers KM; Dellborg M; Johnston N; Oldgren J; Swahn E; Venge P; Lindahl B
    Clin Biochem; 2010 Feb; 43(3):240-5. PubMed ID: 19822136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of myocardial damage prior to hospital admission among patients with acute chest pain or other symptoms raising a suspicion of acute coronary syndrome.
    Svensson L; Isaksson L; Axelsson C; Nordlander R; Herlitz J
    Coron Artery Dis; 2003 May; 14(3):225-31. PubMed ID: 12702926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-sensitivity troponin T as a diagnostic tool for acute coronary syndrome in the real world: an observational study.
    Borna C; Thelin J; Ohlin B; Erlinge D; Ekelund U
    Eur J Emerg Med; 2014 Jun; 21(3):181-8. PubMed ID: 23751287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heart-type fatty acid-binding protein predicts long-term mortality and re-infarction in consecutive patients with suspected acute coronary syndrome who are troponin-negative.
    Viswanathan K; Kilcullen N; Morrell C; Thistlethwaite SJ; Sivananthan MU; Hassan TB; Barth JH; Hall AS
    J Am Coll Cardiol; 2010 Jun; 55(23):2590-8. PubMed ID: 20513600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of B-type natriuretic peptide in addition to troponin I, creatine kinase-MB, and myoglobin on the risk stratification of emergency department chest pain patients with potential acute coronary syndrome.
    Brown AM; Sease KL; Robey JL; Shofer FS; Hollander JE
    Ann Emerg Med; 2007 Feb; 49(2):153-63. PubMed ID: 17084941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid risk stratification in suspected acute coronary syndrome using serial multiple cardiac biomarkers: a pilot study.
    Macdonald SP; Nagree Y
    Emerg Med Australas; 2008 Oct; 20(5):403-9. PubMed ID: 18973637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation of dynamic cardiac troponin I concentrations and C-reactive protein in the monitoring of myocardial infarction in patients with repeated myocardial infarction].
    Plak M; Orliński L; Łobos M; Ciesielczyk M; Wlazeł RN; Paradowski MT
    Pol Merkur Lekarski; 2010 Jun; 28(168):444-9. PubMed ID: 20642101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myeloperoxidase in the diagnosis of acute coronary syndromes: the importance of spectrum.
    Peacock WF; Nagurney J; Birkhahn R; Singer A; Shapiro N; Hollander J; Glynn T; Nowak R; Safdar B; Miller C; Peberdy M; Counselman F; Chandra A; Kosowsky J; Neuenschwander J; Schrock J; Plantholt S; Lewandrowski E; Wong V; Kupfer K; Diercks D
    Am Heart J; 2011 Nov; 162(5):893-9. PubMed ID: 22093206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic information of glycogen phosphorylase isoenzyme BB in patients with suspected acute coronary syndrome.
    Lillpopp L; Tzikas S; Ojeda F; Zeller T; Baldus S; Bickel C; Sinning CR; Wild PS; Genth-Zotz S; Warnholtz A; Lackner KJ; Münzel T; Blankenberg S; Keller T
    Am J Cardiol; 2012 Nov; 110(9):1225-30. PubMed ID: 22818785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heart-type fatty acid binding protein and the diagnosis of acute coronary syndrome in the ED.
    Freund Y; Chenevier-Gobeaux C; Leumani F; Claessens YE; Allo JC; Doumenc B; Cosson C; Bonnet P; Riou B; Ray P
    Am J Emerg Med; 2012 Oct; 30(8):1378-84. PubMed ID: 22169585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abnormal troponin I levels during pregnancy without acute coronary syndrome and without hypertensive disorders.
    Patanè S; Marte F; Di Bella G; Davi' M
    Int J Cardiol; 2008 Aug; 128(2):e47-9. PubMed ID: 17544531
    [No Abstract]   [Full Text] [Related]  

  • 16. Combination of copeptin and troponin assays to rapidly rule out non-ST elevation myocardial infarction in the emergency department.
    Charpentier S; Maupas-Schwalm F; Cournot M; Elbaz M; Botella JM; Lauque D
    Acad Emerg Med; 2012 May; 19(5):517-24. PubMed ID: 22594355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective evaluation of the prognostic implications of improved assay performance with a sensitive assay for cardiac troponin I.
    Bonaca M; Scirica B; Sabatine M; Dalby A; Spinar J; Murphy SA; Jarolim P; Braunwald E; Morrow DA
    J Am Coll Cardiol; 2010 May; 55(19):2118-24. PubMed ID: 20447535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Predictors of acute coronary syndrome without ST segment elevation and risk stratification in the chest pain unit].
    Gabrielli LA; Castro PF; Verdejo HE; McNab PA; Llevaneras SA; Mardonez JM; Corbalán RL
    Rev Med Chil; 2008 Apr; 136(4):442-50. PubMed ID: 18769786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance of glycogen phosphorylase isoenzyme BB is weak in the detection of patients with non-ST-elevation acute coronary syndrome.
    Meune C; Wahbi K; Weber S; Zuily S; Cynober L; Chenevier-Gobeaux C
    Clin Biochem; 2011 Nov; 44(16):1343-5. PubMed ID: 21820423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delta changes for optimizing clinical specificity and 60-day risk of adverse events in patients presenting with symptoms suggestive of acute coronary syndrome utilizing the ADVIA Centaur TnI-Ultra assay.
    Apple FS; Smith SW; Pearce LA; Murakami MM
    Clin Biochem; 2012 Jul; 45(10-11):711-3. PubMed ID: 22465126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.